Public members of the state’s Drug Utilization Review Board are now required to file initial and quarterly disclosures reporting the financial benefits or interests they receive from members of the pharmaceutical industry.

Upon appointment, public members will need to report all meals, payments, gifts, salaries, stocks, or other investments they receive from pharmaceutical managers, pharmaceutical distributors, or pharmacy benefit managers in the preceding three years.

Members of the board will be required to update their financial disclosures quarterly, and reports will be publicly available.